AI assistant
Sending…
LIFECORE BIOMEDICAL, INC. \DE\ — Director's Dealing 2012
May 18, 2012
33431_dirs_2012-05-18_169d0e9b-dcc3-4b79-b6aa-d0ab7759d988.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LANDEC CORP \CA\ (LNDC)
CIK: 0001005286
Period of Report: 2012-05-16
Reporting Person: Tobin Robert (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-05-16 | Stock Option (Right to Buy) | $6.66 | M | 5000 | Acquired | 2019-05-16 | Common Stock (5000) | Direct |
| 2012-05-16 | Restricted Stock Unit (RSU) | $ | M | 1667 | Acquired | Common Stock (1667) | Direct |
Footnotes
F1: Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock.
F2: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis
More from LIFECORE BIOMEDICAL, INC. \DE\
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Director's Dealing
2026
Mar 3
Board/Management Information
2026
Jan 16
Investor Presentation
2025
Nov 17
Interim / Quarterly Report
2025
Nov 6
Earnings Release
2025
Nov 6
Declaration of Voting Results & Voting Rights Announcements
2025
Oct 31
Major Shareholding Notification
2025
Oct 17
Regulatory Filings
2025
Oct 1